Insider · CIK 0001507174
LaBarre Michael J.
officer
Files at HALO (HALOZYME THERAPEUTICS, INC.). First filing Oct 16, 2024, latest Oct 16, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.1M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 10Weak | sell10b5-1 | HALO HALOZYME THERAPEUTICS, INC. | $1.1M | 20,000 | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +5,509 | $16.65 | $92k | 179,265 | Oct 16, 2024 |
| Oct 15, 2024 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +4,491 | $19.98 | $90k | 183,756 | Oct 16, 2024 |
| Oct 15, 2024 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -9,923 | $53.74 | $533k | 173,833 | Oct 16, 2024 |
| Oct 15, 2024 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -77 | $54.25 | $4,177 | 173,756 | Oct 16, 2024 |
| Oct 16, 2024 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +10,000 | $19.98 | $200k | 183,756 | Oct 16, 2024 |
| Oct 16, 2024 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -10,000 | $53.26 | $533k | 173,756 | Oct 16, 2024 |
| Oct 15, 2024 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -5,509 | $0.00 | $0 | 6,352 | Oct 16, 2024 |
| Oct 15, 2024 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -4,491 | $0.00 | $0 | 36,608 | Oct 16, 2024 |
| Oct 16, 2024 | HALO HALOZYME THERAPEUTICS, INC. | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -10,000 | $0.00 | $0 | 26,608 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.